Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Laboratory Corp. of America Holdings
Headquarters: Burlington, NC, United States of America
Website: http://www.labcorp.com
Year Founded: 1971
Status: Public
Industry Sector: HealthServices
CEO: Adam H. Schechter
Number Of Employees: 70,000
Enterprise Value: $25,123,008,844
PE Ratio: 26.42
Exchange/Ticker 1: NYSE:LH
Exchange/Ticker 2: N/A
Latest Market Cap: $19,540,600,832
BioCentury | Sep 25, 2023
Product Development
Sept. 25 Quick Takes: Novartis’ Lutathera meets primary for first-line GEP-NETs
Plus: Japan’s latest drug approvals and updates from Junshi, Adela, AbbVie, I-Mab, Novo, Valo, BridgeBio, GSK, Scynexis
BioCentury | Nov 30, 2022
Politics, Policy & Law
Merck, Johns Hopkins dispute Keytruda patents
University seeking hundreds of millions of dollars from Merck
BioCentury | Sep 27, 2022
Management Tracks
DEM names Grmusa CEO, Quéva CSO
Plus 5AM adds Arthur Tzianabos, June Lee as venture partners, and updates from Woebot, Flagship Biosciences and Radionetics
BioCentury | Jul 28, 2022
Finance
July 28 Quick Takes: Merck to expand Keytruda’s reach as sales top $5B
Plus venture rounds for BridGene, Ozette and updates from argenx, Elevation-CSPC and more
BioCentury | May 28, 2022
Discovery & Translation
A synthetic lethal pair; plus Arbor and more
BioCentury’s roundup of translational news
BioCentury | Jan 19, 2022
Politics, Policy & Law
Industry leaders call for unified pandemic preparedness policy
Mammen, Narasimhan and colleagues detail priorities for lawmakers, White House
BioCentury | Oct 15, 2021
Politics, Policy & Law
Califf’s corporate connections will be scrutinized
The former FDA commissioner works for Verily, serves on the boards of Cytokinetics, Centessa, Clinetic
BioCentury | Aug 24, 2021
Deals
Aug. 23 Quick Takes: Pfizer, BioNTech look ahead to pediatric data after FDA approval of Comirnaty
Approval for COVID-19 vaccines from Zydus Cadila, Medigen-Dynavax; plus Sabatini fired, Clover’s U.S. beachhead and more
BioCentury | Jun 10, 2021
Deals
June 9 Quick Takes: Datavant, Ciox in health data merger; plus G7 plan, WTO, Merck and more
Datavant Inc. and Ciox Health believe their merger will create a health data network that will improve patient outcomes and reduce costs, overcoming data fragmentation by building a unified ecosystem.
BioCentury | May 18, 2021
Finance
May 18 Quick Takes: Temasek backs Wilson, Yamada to form G2 Bio; plus PathAI, Interius, Vedere II and more
Singapore-based Temasek will supply $200 million to G2 Management Co. Inc. to foster the development of therapies from the University of Pennsylvania's Gene Therapy Program, led by James Wilson.
Items per page:
1 - 10 of 247